3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
3
Myofibroma
1
Menorrhagia
1
Interventions
estradiol, norethindrone drug combination
2
elagolix
2
Norethindrone Acetate
2
Estradiol
2
vilaprisan
1
ulipristal
1
Progesterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Menorrhagia
×
ulipristal
×
Clear all
NCT02465814
2016-11-22
ASTEROID 2
Bayer
Phase 2
Completed
120 enrolled